Treatment of macular edema due to retinal vein occlusions. - Wikidata - wikimedia - TriplyDB

Treatment of macular edema due to retinal vein occlusions.

Treatment of macular edema due to retinal vein occlusions.

http://www.wikidata.org/entity/Q33918085

about

Evaluating the impact of vitreomacular adhesion on anti-VEGF therapy for retinal vein occlusion using machine learning Diabetic macular edema: therapeutic options.Glucocorticoid induction of occludin expression and endothelial barrier requires transcription factor p54 NONO Differences in aqueous concentrations of cytokines in macular edema secondary to branch and central retinal vein occlusion Retinal Vein Occlusion in Benin City, Nigeria.Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion Central retinal vein occlusion associated with high blood levels of lipoprotein (a).: Is lipoprotein (a) a reliable marker for identification of predisposed individuals?Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion

P2860

Q33774284-E66A0F19-D6D7-464E-8241-42AFB4D0C637 Q34185374-E602457B-21AB-4D47-8E55-CE5904ED33BF Q34703697-43C24BAC-2518-415F-9DE3-EAB166C97AF6 Q34826956-96407BF5-58A0-4DD5-A845-A0CC825B1340 Q35970017-E87C1C2F-4F8D-4469-A3B6-963CA0BBCDBF Q42035309-5B3584C9-87B0-4C59-83F9-E57D4437214B Q42350831-5CD5C026-9F6A-46BA-BE7D-8DC69C203ED3 Q58567790-410186E4-8779-43EC-9608-A9BD87C72D78 Q58770137-5BE65849-FB9F-4317-915F-9A562058C6E9

P2860

Treatment of macular edema due to retinal vein occlusions.

http://www.wikidata.org/entity/Q33918085

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Treatment of macular edema due to retinal vein occlusions.

@ast

Treatment of macular edema due to retinal vein occlusions.

@en

type

label

Treatment of macular edema due to retinal vein occlusions.

@ast

Treatment of macular edema due to retinal vein occlusions.

@en

prefLabel

Treatment of macular edema due to retinal vein occlusions.

@ast

Treatment of macular edema due to retinal vein occlusions.

@en

P1433

Q33918085-497F009C-0D4F-4D9F-A22E-15C2F1245000

P1476

Q33918085-23468E6D-8DAB-448D-8386-D2A600846625

P2093

Q33918085-5FBBA7CA-3E75-4380-A92C-B650AC80638A

Q33918085-A83E05D0-63AA-4D1E-A775-4CCD0E228EF4

Q33918085-F7AAAD75-CF86-4232-BAC4-06D6DF59F115

P2860

Q33918085-1AFC462C-6A63-4A8F-99E8-5CC045A4D60D

Q33918085-27669D21-92F3-4C17-800F-46DBECFA5577

Q33918085-52AC902C-704D-4ECE-9AFA-D3723958D0B1

Q33918085-613CA8B0-AEBA-4D48-8064-983B683FE8C9

Q33918085-6E4604A7-E3C8-46A4-A434-0FF12680AD4D

Q33918085-8B76579A-1AB7-4CDF-951F-C9DB3000B14D

Q33918085-A209776D-80C1-451E-97B7-2B06670A1437

Q33918085-AA34FDFE-D969-449A-BCE8-F9CF6CA1E227

Q33918085-AAD9CAED-A3ED-4570-8C3B-5A990AEE10B4

Q33918085-ADDD5D7E-567D-4C61-A0CF-8C8C4C0D456D

P304

Q33918085-925912BD-6669-4344-B0CD-470E56A2175D

P31

Q33918085-F6193BF2-2B5B-4DB2-8B37-5293C0949346

P356

Q33918085-29DA2F9E-1CD0-40F4-9968-109F631C7068

P407

Q33918085-DA51CF24-C4A0-4322-952E-5515CC2C9437

P478

Q33918085-37C5F41A-2226-49A9-BF00-30416AFBE988

P577

Q33918085-6AFB6DB0-F092-470D-8C28-A7AE4370AF6B

P698

Q33918085-A200FE32-C480-477A-B62D-AC5A67E39566

P932

Q33918085-AC0BC44C-CF79-4FA7-A3E3-E37C40636BAA

P356

P1433

Clinical Ophthalmology

P1476

Treatment of macular edema due to retinal vein occlusions.

@en

P2093

Michael Smith

http://www.w3.org/2001/XMLSchema#string

Peter A Campochiaro

http://www.w3.org/2001/XMLSchema#string

Roomasa Channa

http://www.w3.org/2001/XMLSchema#string

P2860

The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein

Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study

Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.

Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.

Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema.

Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes.

Monitoring ocular drug therapy by analysis of aqueous samples.

Retinal vein occlusion: evaluation of "classic" and "emerging" risk factors and treatment.

P304

705-713

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OPTH.S7632

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21629578

http://www.w3.org/2001/XMLSchema#string

P932

3104801

http://www.w3.org/2001/XMLSchema#string